Skip to menu Skip to content Skip to footer
Dr John Mackintosh
Dr

John Mackintosh

Email: 

Overview

Background

MBBS(Hons), FRACP — Specialist Respiratory and Lung Transplant Physician

Dr John Mackintosh graduated from The University of Queensland in 2011 with honours. He trained in respiratory medicine in Queensland, before completing an interstitial lung disease clinical fellowship at the Royal Brompton Hospital in London — one of the world's leading interstitial lung disease (ILD) referral centres.

He returned to Brisbane in 2019 as a Respiratory & Lung Transplant Physician with the Queensland Lung Transplant Service at The Prince Charles Hospital, and as an academic at The University of Queensland, where he was promoted to Associate Professor in recognition of his clinical and research contribution to ILD. He leads The Prince Charles Hospital's ILD service and his research work centres on ILD, with particular expertise in idiopathic pulmonary fibrosis, familial pulmonary fibrosis and the genetic underpinnings of fibrotic lung disease.

Alongside his clinical practice, he co-chairs the Queensland Statewide ILD Multidisciplinary Meeting and is founder and chair of the Australasian ILD Genetics Multidisciplinary Meeting. Internationally, he was a Co-Lead for the International Society of Heart and Lung Transplantation's first consensus statement on short telomere syndrome and lung transplantation, and is first author of the current Thoracic Society of Australia and New Zealand position statement on the treatment of IPF and progressive pulmonary fibrosis.

Availability

Dr John Mackintosh is:
Not available for supervision

Research impacts

Dr Mackintosh's research centres on interstitial lung disease, with a particular focus on the genetics of pulmonary fibrosis, telomere biology disorders and outcomes after lung transplantation.

Works

Search Professor John Mackintosh’s works on UQ eSpace

22 works between 2014 and 2026

21 - 22 of 22 works

2019

Journal Article

Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression

Mackintosh, John A., Marshall, Henry M., Slaughter, Richard, Reddy, Taryn, Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2019). Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression. Internal Medicine Journal, 49 (7), 843-849. doi: 10.1111/imj.14148

Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over two years of surveillance: ILAs in QLCSS prevalence and progression

2014

Journal Article

A retrospective study of volume doubling time in surgically resected non-small cell lung cancer

Mackintosh, John A., Marshall, Henry M., Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2014). A retrospective study of volume doubling time in surgically resected non-small cell lung cancer. Respirology, 19 (5), 755-762. doi: 10.1111/resp.12311

A retrospective study of volume doubling time in surgically resected non-small cell lung cancer

Funding

Current funding

  • 2023 - 2028
    Treatable Traits in Interstitial Lung Disease (TTRILD) Study: The New Frontier (MRFF Preventive and Public Health Research Initiative grant administered by The University of Western Australia)
    University of Western Australia
    Open grant

Past funding

  • 2020 - 2025
    The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis?
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Media

Enquiries

For media enquiries about Dr John Mackintosh's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au